Effect of interferential current on TNF Alpha and chemotherapy induced neuropathic pain.

Effect of Interferential current on control of neuropathic pain and TNF a serum level in cancer patients after chemotherapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201502164203N9

Enrollment

Registered

2015-04-29

Start date

2015-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paraneoplastic neuromyopathy and neuropathy. Paraneoplastic neuromyopathy and neuropathy

Interventions

Intervention 1: Intervention:Interferential current on affected limb, for 15 minuntes, 5 times per weeks, for 2 weeks (10 sessions). Intervention 2: control: inactive device(placebo). in off mode on

Treatment - Devices

Rehabilitation

Intervention:Interferential current on affected limb, for 15 minuntes, 5 times per weeks, for 2 weeks (10 sessions)

control: inactive device(placebo). in off mode on affected limb, for 15 minuntes, 5 times per weeks, for 2 weeks (10 sessions).

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria:Patients receiving chemotherapy drugs with Paclitaxel or Oxaliplatin and passed at least four weeks of chemotherapy treatment; Age greater than 18 years ; Are expected to live more than three months; Average daily pain score greater than 5. Exclusion Criteria: Receiving the first dose of chemotherapy drug is less than four weeks or neuropathic pain is a cause other than chemotherapy; Detection of metastases to the brain or spinal cord; the patient to other research related to pain within 30 days, non-intervention previous intervention plan for pain control; pregnant women or active use of birth control pills; having coronary artery disease within 6 months; history of seizures; any form of metal medical devices such as pacemakers for heart patients; the bad condition of the skin, placing electrodes on the skin to prevent those things near the tumor or acute bacterial infection is present; patients before the end of the plan will require re-treatment chemotherapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Chemotherapy induced neuropathic pain. Timepoint: Before intervention, after 10 sessins of intervention. Method of measurement: Visual analogue scale(vas).	—

Secondary

Measure	Time frame
Serum TNF a level. Timepoint: Before intervention, after 10 sessions of intervention. Method of measurement: measurement kit of the TNF a.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Atefeh Aminian Far

Semnan University of Medical Sciences

aminfar@sem-ums.ac.iraminfar83@yahoo.com+98 23 3365 4180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026